£515.00

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 3 months

The 2023-2028 Outlook for Substance Abuse Treatments in India

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 78 days · 78 data points (no recent data)

Historical
Generating forecast…
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 25 July 2026 13 August 2026 01 September 2026 20 September 2026 10 October 2026
View at Amazon ↗

Price data last checked 13 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 78 days • 1 price levels

Days at Price
78 days 0 20 39 59 78 £515 Days at Price

Price Analysis

Most common price: £515 (78 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 78 days

Description

This study covers the latent demand outlook for substance abuse treatments across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is of its state or union territory and of India as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state, union territory, and city, latent demand estimates are created for substance abuse treatments. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of substance abuse treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Alkermes, Allergan, BioCorRx, GlaxoSmithKline, Glenmark Pharmaceuticals, Indivior, Mallinckrodt, Mylan NV, Noramco (part of SK Capital Partners), Pfizer, Purdue Pharma, Reckitt Benckiser Group, Sanofi, and Teva Pharmaceutical Industries. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
28 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Substance Abuse Treatments in the United States
99% match

The 2023-2028 Outlook for Substance Abuse Treatments in the United States

£520.00 11 Oct 2026
The 2023-2028 Outlook for Substance Abuse Treatments in Japan
99% match

The 2023-2028 Outlook for Substance Abuse Treatments in Japan

£495.00 17 Oct 2026
The 2023-2028 Outlook for At-Home Drug of Abuse Testing in India
98% match

The 2023-2028 Outlook for At-Home Drug of Abuse Testing in India

£515.00 05 Sep 2026
The 2023-2028 Outlook for At-Home Drug of Abuse Testing in the United States
97% match

The 2023-2028 Outlook for At-Home Drug of Abuse Testing in the United States

£520.00 09 Sep 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India
97% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India

£515.00 21 Aug 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
97% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 20 Aug 2026
The 2027-2032 World Outlook for Alcoholism Rehabilitation Hospitals
97% match

The 2027-2032 World Outlook for Alcoholism Rehabilitation Hospitals

£890.00 14 Oct 2026
The 2023 Report on At-Home Drug of Abuse Testing: World Market Segmentation by City
97% match

The 2023 Report on At-Home Drug of Abuse Testing: World Market Segmentation by City

£795.00 04 Sep 2026
The 2023-2028 Outlook for Over the Counter Drugs in India
97% match

The 2023-2028 Outlook for Over the Counter Drugs in India

£515.00 20 Aug 2026
The 2023-2028 Outlook for Medical Devices for Opioid Use Disorder and Drug Addiction Treatments in the United States
97% match

The 2023-2028 Outlook for Medical Devices for Opioid Use Disorder and Drug Addiction Treatments in the United States

£520.00 06 Sep 2026
Substance Abuse: Treatment Plans and Sober Living Homes (Substance Abuse Assessment, Interventions and Treatment)
97% match

Substance Abuse: Treatment Plans and Sober Living Homes (Substance Abuse Assessment, Interventions and Treatment)

£120.95 12 Aug 2026
The 2023-2028 Outlook for Ad-Based Music Streaming Services in India
97% match

The 2023-2028 Outlook for Ad-Based Music Streaming Services in India

£515.00 02 Oct 2026
Substance Use Disorders and Behavioral Addictions: A Comprehensive Guide
97% match

Substance Use Disorders and Behavioral Addictions: A Comprehensive Guide

Springer

£549.99 26 Aug 2026
The 2023-2028 Outlook for Digital Therapeutics Sales in India
97% match

The 2023-2028 Outlook for Digital Therapeutics Sales in India

£515.00 25 Aug 2026
The 2023 Report on Bioactive Substances: World Market Segmentation by City
97% match

The 2023 Report on Bioactive Substances: World Market Segmentation by City

£795.00 12 Aug 2026
Substance Abuse - New Compounds and New Problems
97% match

Substance Abuse - New Compounds and New Problems

IntechOpen

£119.00 19 Sep 2026
The 2023-2028 Outlook for Alcohol Addiction Treatments in Japan
97% match

The 2023-2028 Outlook for Alcohol Addiction Treatments in Japan

£495.00 03 Sep 2026
Subjective Definitions of Substance Abuse Problems:: Does Age Matter?
97% match

Subjective Definitions of Substance Abuse Problems:: Does Age Matter?

VDM Verlag

£42.00 14 Oct 2026
The 2023-2028 Outlook for Education and Training Services in India
97% match

The 2023-2028 Outlook for Education and Training Services in India

£515.00 06 Sep 2026
The 2023-2028 Outlook for 4K Technologies in India
97% match

The 2023-2028 Outlook for 4K Technologies in India

£515.00 26 Aug 2026
The 2023-2028 Outlook for Drugstores in India
97% match

The 2023-2028 Outlook for Drugstores in India

£515.00 25 Aug 2026
The 2023-2028 Outlook for Opioids in the United States
97% match

The 2023-2028 Outlook for Opioids in the United States

£520.00 25 Aug 2026
The 2023-2028 Outlook for Mobile Medical Apps in India
97% match

The 2023-2028 Outlook for Mobile Medical Apps in India

£515.00 22 Aug 2026
The 2023-2028 Outlook for Intelligent Apps in India
97% match

The 2023-2028 Outlook for Intelligent Apps in India

£515.00 25 Aug 2026